Meridian Bioscience Competitors and Similar CompaniesClear all

Meridian Bioscience's competitors and similar companies include Varex Imaging, MetaboGen AB, Cisbio and Alpha Diagnostic.

	Meridian Bioscience Meridian Bioscience is a life science company which develops, manufactures, and distributes diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide.	Varex Imaging Varex Imaging is a developer and manufacturer of X-ray imaging components.	MetaboGen AB As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.	Cisbio Cisbio is a company that develops and markets products and technologies used for in vitro diagnostics and drug discovery.	Alpha Diagnostic Alpha Diagnostic International (ADI) is a biotech company providing diagnostic reagents and test kits for animal and human diseases.
Founding Date	Founding Date 1977	Founding Date 2017	Founding Date 2011	Founding Date 1985	Founding Date 1993
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare Manufacturing & Industrial Technology biotech distribution life sciences medical diagnostics pharma platform	Tags Manufacturing & Industrial electronic components imaging medical devices medical imaging medtech	Tags Healthcare Technology biotech healthtech medical diagnostics pharma platform	Tags Healthcare biotech life sciences medical diagnostics pharma	Tags Healthcare biotech distribution drug development life sciences medical diagnostics medtech pharma
Locations	Locations Cincinnati, US HQ Eveleigh, AU Braine L'alleud, BE Québec, CA Paris, FR Luckenwalde, DE Modi'in Maccabim Re'ut, IL see more	Locations Salt Lake City, US HQ Wuxi, CN Walluf, DE Willich, DE Milano, IT Doetinchem, NL Calamba, PH see more	Locations Mölndal, SE HQ Stockholm, SE	Locations Codolet, FR HQ	Locations San Antonio, US HQ San Antonio, US
Employees	Employees 66013% increase	Employees 2,4004% increase	Employees 1	Employees 1111% decrease	Employees N/A
Valuation ($)	Valuation ($) 1.5 b	Valuation ($) 543.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $333m (FY, 2022)	Revenue (est.) $844.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $144.7m (FY, 2022)	Cost of goods $554.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $188.4m (FY, 2022)	Gross profit $290.5m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income $42.5m (FY, 2022)	Net income ($69.9m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A